Sahab Yaqubi, MD
Dr. Sahab Yaqubi is a board-certified Oakland psychiatrist with a strong specialty in helping patients struggling with Clinical Depression, Bipolar Disorder, and anxiety disorders.

More about Sahab Yaqubi
Dr. Sahab Yaqubi completed a fellowship in Psychosomatic Medicine and is experienced in treating neuropsychiatric disorders, e.g., Dementia or Parkinson’s disease associated with mood or anxiety. He is also trained in psychodynamic psychotherapy and Cognitive Behavioral Therapy. Dr. Yaqubi takes a holistic approach to patient care and treatment plans, considering biological, psychological, and social factors. He has found that being in tune with his patient’s emotional pain is the key to developing a good rapport. To empathize with his patient’s emotional pain and be able to reduce their suffering is his focus at all times.
Through his years of treating patients with clinical depression and other mood disorders, medication management and therapy are basic tools that he has used successfully to find relief from suffering. But not all the patients fully respond to these therapeutic tools. For Dr. Yaqubi, Transcranial Magnetic Stimulation (TMS) therapy in Oakland is another non-invasive therapeutic tool that can play a crucial role for those with treatment-resistant mood or anxiety disorders.
Dr. Sahab Yaqubi joined Mindful Health Solutions in early 2021.
Personal Interests
Being a nature lover, he enjoys spending his free time hiking, camping, biking, running. When not outdoors embracing the beauty of Northern California, he also spends his time traveling, reading, or pursuing his interest in ballroom dance.
Education & Experience
Certifications & Memberships
- Board Certified, American Board of Psychiatry and Neurology
- Board Certified, American Board of Psychosomatic Medicine/ Consultation-Liaison Psychiatry
- Member, American Psychiatric Association
- Member, Academy of Consultation-Liaison Psychiatry
Publications
James W. Murrough, Sahab Yaqubi, Sehrish Sayed, Dennis S. Charney. “Emerging Drugs for the Treatment of Anxiety”. Expert Opin Emerg Drugs 2015 May 26:1-14. Cited in PubMed; PMID: 26012843
Hamid M Abdolmaleky, Sahab Yaqubi, Panos Papageorgis, Arthur W. Lambert, Sait Ozturk, Vadivelu Sivaraman and Sam Thiagalingam. “Epigenetic dysregulation of HTR2A in the Brain of patients with schizophrenia and bipolar disorder”. Schizophrenia Research 129 (2011) pp. 183-190. Cited in PubMed; PMID: 21550210
Rahim Shafa, Hamid Abdolmaleky, Sahab Yaqubi, Casandra L Smith, Nassir Ghaemi. Entacapone as an Anti-Craving Treatment in Substance Abuse and Dependence. The American Journal on Addictions 17(4), pp. 331-332, 2008
Brian Medina, Sahab Yaqubi, Kara Martin, Bill Lin and Ahmad Salehi.” Increased Gaba-ergic terminals in Ts65Ds mice could be linked to a fragment of MMU16 between MRPL39 to TIAM1 genes.” Poster, Presented in Stanford Institute for Neuro-Innovation and Translational Neurosciences Annual Neuroscience Research Conference Oct2011, Watsonville, CA.